fluorobenzenes has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasberg, RG; Huang, R; Lewis, JS; Pillarsetty, N; Serganova, I; Thorek, DL; Vaidyanathan, G; Zhang, H | 1 |
| Albani, D; Confaloni, A; Crestini, A; Forloni, G; Iazeolla, M; Piscopo, P; Rivabene, R | 1 |
2 other study(ies) available for fluorobenzenes and Glioma
| Article | Year |
|---|---|
Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
Topics: Animals; Cell Line, Tumor; Fluorobenzenes; Glioma; Guanidines; Humans; Mice; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2014 |
Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Cell Line, Tumor; Enzyme Inhibitors; Fluorobenzenes; Gene Expression; Glioma; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Thapsigargin | 2011 |